Clear market notes built around the JSE, the rand, and what matters locally.

2026-07-16 22:31 • The Motley Fool Positive Axe Cap view: Selective

Credo Technology Group's COO Yat Tung Lam sold 50,000 shares worth $11.3 million on July 15, 2026, through a pre-planned Rule 10b5-1 trading arrangement. Despite the sale, Lam maintains over 3 million shares in the company. The article characterizes this as routine profit-taking after the stock's 121% one-year run, not a sign of concern. Credo reported strong fiscal results with revenue exceeding $1.3 billion and net income of $472.3 million, though the company faces concentration risk with 90% of revenue from its top 10 customers.

Axe note: Credo’s COO sold $11.3 million in shares after a stellar 121% rally, illustrating routine profit-taking amid strong growth but notable customer concentration risk.

2026-07-16 22:12 • The Motley Fool Positive Axe Cap view: Selective

AtaiBeckley shares surged 33.40% after pharmaceutical giant Eli Lilly agreed to acquire the mental health-focused biotechnology company for $6.75 per share in cash, plus up to $2.50 per share in milestone payments. The total deal valuation could reach approximately $3.8 billion if all conditions are met. The acquisition is expected to close in Q3, subject to shareholder and regulatory approval.

Axe note: Eli Lilly’s acquisition of AtaiBeckley highlights growing global interest in innovative mental health therapies with some ripple effects for local biotech sentiment.

2026-07-16 22:11 • The Motley Fool Neutral Axe Cap view: Selective

IBM stock plummeted over 25% following an earnings warning, erasing $67 billion in market value. The decline was triggered by customers shifting spending away from IBM's software toward AI servers and memory chips. While the short-term outlook is concerning, the analyst views this as a cyclical timing issue rather than a fundamental problem, suggesting the crash may present a buying opportunity for patient investors.

Axe note: IBM’s sharp plunge faced a cyclical shift in tech spending—worth watching, but not without risks.